Operational Highlights - 2008:
-- In January 2008, GeoVax was recognized by Georgia Bio, the state trade
organization, as a 2007 "Deal of the Year" award winner for receipt of
the $15 million IPCAVD grant from the National Institutes of Health
(NIH). The award was presented at Georgia Bio's annual awards dinner on
January 24, 2008. This grant is believed to be one of the largest
grants of its kind to be awarded in the last fiscal year.
-- In February 2008, GeoVax announced the addition of company co-founder
Dr. Harriet Robinson to its staff as Vice President of Research &
Development. Dr. Robinson is known worldwide for her outstanding work
on retrovirus biology and a pioneer of DNA vaccines with special
emphasis on HIV/AIDS. Dr. Robinson has published extensively on
HIV/AIDS vaccine research, with more than 150 referred scientific
journal publications, 50 monograph reviews and six book chapters
authored. She has consulted for the U.S. National Institutes of Health,
the U.S. Food and Drug Administration, the Bill and Melinda Gates
Foundation and the World Health Organization. She served as Chief of
Microbiology and Immunology at Emory University's Yerkes National
Primate Research Center and was an Asa Griggs Candler Professor of
Microbiology and Immunology at the Emory University School of Medicine.
Dr. Robinson is the inventor of GeoVax's HIV-1 AIDS vaccine tech
|SOURCE GeoVax Labs, Inc.|
Copyright©2008 PR Newswire.
All rights reserved